Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas [Phase 2]
Phase 2 study evaluating maintenance therapy after first-line chemotherapy in metastatic pancreatic cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating SBRT for locally advanced unresectable pancreatic cancer has completed.
-
FDA approval · 2022-09-14FDA Approved: FLUOROURACIL — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for fluorouracil submitted by BluePoint Laboratories, indicating approval of an ANDA supplement. Thi…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, with stated gastric, colon, rectal, esopha…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy [Phase 2]
Phase 2 trial evaluating regorafenib in metastatic solid tumors that progressed after standard therapy has completed, with multiple indicate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer [Phase 2]
Phase 2 trial investigating nivolumab plus ipilimumab with radiation in metastatic pancreatic cancer is currently active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: First-line Therapy in Metastatic PDAC [Phase 2]
A Phase 2 clinical trial update investigating first-line therapy for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating adjuvant GVAX vaccine therapy after surgery for pancreatic cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Effect of Hemp-CBD on Patients With CIPN [Phase 2]
Phase 2 clinical trial investigating the effect of hemp-derived CBD on chemotherapy-induced peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) [Phase 2]
Phase 2 clinical trial update for Flouro-Gem in pancreatic adenocarcinoma (GEFLUPAN) has completed enrollment; results not provided in snipp…
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer [Phase 3]
Phase 3 clinical trial evaluating organoid-guided adjuvant chemotherapy for pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer [Phase 3]
Phase 3 clinical trial update on organoid-guided chemotherapy for advanced pancreatic cancer.
-
FDA approval · 2022-07-27FDA Approved: PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND — Original Application (American Regent, Inc.)
FDA approved paclitaxel protein-bound particles albumin-bound (paclitaxel) from American Regent, Inc. under an Original Application (NDA2118…
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) [Phase 2]
A Phase 2 trial evaluating azacitidine for patients with resected pancreatic cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer [Phase 4]
Phase 4 clinical trial evaluating quality of life after biliodigestive anastomosis or stents for biliary obstruction in pancreatic cancer; s…
-
FDA approval · 2022-06-22FDA Approved: ERLOTINIB — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic erlotinib product. Erlotinib is used to treat certain cancers…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes [Phase 2]
Phase 2 trial evaluating intravenous human albumin to improve outcomes after pancreaticoduodenectomy, including pancreatic fistula and relat…
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating induction FOLFIRINOX followed by chemoradiation for locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer [Phase 1, Phase 2]
Phase 1/2 trial of M7824 (immune checkpoint inhibitor) and M9241 (immunocytokine) with SBRT in adults with advanced pancreatic cancer; study…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer [Phase 2]
Phase II trial evaluating BI 2536, a PLK-1 inhibitor, in advanced, unresectable pancreatic cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer. [Phase 2]
Phase 2 exploratory trial evaluating sintilimab with albumin-bound paclitaxel and gemcitabine for unresectable locally advanced pancreatic c…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC [Phase 1, Phase 2]
Open-label Phase I/II trial evaluating the PLENA regimen for unresectable pancreatic cancer or biliary tract cancer.
-
CLINICAL_TRIALS withdrawal · 2022-04-01Clinical Trial Update: Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases [Phase 2, Phase 3]
A study evaluating anti-CEA CAR-T plus chemotherapy versus chemotherapy alone in pancreatic cancer with liver metastases has been withdrawn …
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating whether thromboprophylaxis impacts progression-free survival in advanced pancreatic cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial exploring Envafolimab in combination with Endostar and chemotherapy as first-line treatment for advanced pancreatic cancer.